4Dmedical - The Long Breath
4DX delivered FY24 revenue up 5x to $3.8m (OMLe $3.9m), GP of $3.5m (OMLe $3.6m) and an EBITDA loss of -$30.5m (OMLe -$27.9m).
360 Views
4DMedical - Pricing Step-Change
With the timing of the Philips reseller agreement weighing on investors, we believe 4DX’s improving US commercialisation trajectory is being...
164 Views
4Dmedical Limited - Significant Progress in 1H24
4DX’s 1H24 result was largely in-line with OMLe across key metrics (revenue, cash flows, balance sheet), noting the majority were pre-reported at...
302 Views
4DMedical Limited - Owning the Lung
4DX is a global medical technology company focused on the commercialisation of its flagship respiratory imaging platform, XV Technology.
313 Views
No more insights